当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › European Journal of Pharmaceutical Sciences杂志
European Journal of Pharmaceutical Sciences
基本信息
期刊名称 European Journal of Pharmaceutical Sciences
EUR J PHARM SCI
期刊ISSN 0928-0987
期刊官方网站 https://www.sciencedirect.com/journal/european-journal-of-pharmaceutical-sciences
是否OA Yes
出版商 Elsevier B.V.
出版周期 Monthly
文章处理费 登录后查看
始发年份 1993
年文章数 259
影响因子 4.3(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 PHARMACOLOGY & PHARMACY 药学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 9.6 0.752 1.059
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
20/183 89%
补充信息
自引率 2.3%
H-index 119
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0928-0987%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/phasci/default.aspx
收稿范围
European Journal of Pharmaceutical Sciences is the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS).

The journal publishes research articles, review articles, perspectives and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and drug development.

More specifically, the European Journal of Pharmaceutical Sciences publishes reports on:
drug absorption and metabolism,
drug delivery including nucleic acid delivery,
drug evaluation in the clinic,
drug targeting,
medicinal chemistry,
personalised and precision medicine,
pharmaceutical and biomedical analysis,
pharmaceutical biotechnology,
pharmaceutical technology and manufacturing,
pharmacodynamics,
pharmacokinetics,
pharmacology including translational pharmacology,
physical chemistry related to formulation, physical pharmacy and preformulation,
regulatory science.
New chemical entities, new biological entities, prodrugs, peptides and new modalities such as antibody-drug-conjugates (ADCs), PROTACs, advanced therapy medicinal products (ATMPs) including nucleic acid modalities (e.g., siRNA or mRNA), cell-based therapies are within the scope of the journal.

Manuscripts describing new technical aspects such as new methods, new routes of synthesis, new formulation approaches, applied engineering, nanotechnology or the use of in silico tools for modelling and pharmaceutical data science are welcome.

European Journal of Pharmaceutical Sciences publishes contributions dealing with relevant aspects of pediatrics, treatment of elderly patients e.g., impaired pharmacokinetics. Manuscripts covering rare diseases, are also within the scope of the journal.

The journal will typically not give priority to manuscripts focusing exclusively on organic synthesis of bioactive small molecules and adaptation of analytical approaches, unless they prove to be of key importance in the drug discovery and development process. Topics or discussions pertaining to drug policy making do not have priority. In silico studies, such as molecular modelling, bulk scale modelling and virtual screening, unless reporting novel and broadly applicable methods, can be considered only if supported by experimental studies and verification of the pharmaceutical relevance of modelling results. Homeopathic medicines, phytochemical and pharmacological studies on plant extracts, traditional Chinese medicines and of isolated drug compounds of natural origin are not in the focus for European Journal of Pharmaceutical Sciences.

Review articles, perspectives and scientific commentaries are generally by invitation or by consent of the Editors. Proceedings of scientific meetings may be published as special issues upon discussions with the Editor/Publisher.
收录体裁
Research articles
Review articles
Commentaries and Mini-reviews
Commentaries (Guidance)
Mini-review (Guidance)
投稿指南 https://www.sciencedirect.com/journal/european-journal-of-pharmaceutical-sciences/publish/guide-for-authors
投稿模板
参考文献格式
编辑信息
Editor-in-Chief

Martin Brandl

Dept. of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, DK-5230, Odense M, Denmark 
Section Editors

Cosimo Altomare

Università degli Studi di Bari Aldo Moro, Bari, Italy
Trinity College Dublin, Dublin, Ireland

Jelena Filipović-Grčić

Sveučilišta u Zagrebu, Zagreb, Croatia

Jukka Rantanen

University of Copenhagen, Copenhagen, Denmark

Christoph Ritter

University of Greifswald, Greifswald, Germany

Christoph Saal

Merck KGaA, Darmstadt, Germany

Bruno Sarmento

Universidade do Porto, Porto, Portugal

Stephan Schmidt

University of Florida, Orlando, Florida, USA

Nataša Škalko-Basnet

Universitetet i Tromsø, Tromsø, Norway
KU Leuven, Leuven, Belgium
The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
Editorial Board

L.J. Aarons

University of Manchester, Manchester, UK

F. Ahsan

Texas Tech School of Pharmacy, Amarillo, Texas, USA

J.M. Aiache

University of Clermont-Ferrand, Clermont-Ferrand, France

M.J. Alonso

Universidade de Santiago de Compostela, Santiago de Compostela, Spain

P. Artursson

Uppsala Universitet, Uppsala, Sweden

B. Aungst

AUC Sciences, Newark, Delaware, USA

S. Auriola

University of Eastern Finland, Kuopio, Finland

A. Avdeef

in-ADME Research, New York, New York, USA

M. Bermejo Sanz

Universidad Miguel Hernández (UMH), San Juan de Alicante, Spain

O.J. Bjerrum

University of Copenhagen, Copenhagen, Denmark

H.H. Blume

Socratec R&D, Oberursel, Germany

J.A. Bouwstra

Leiden/Amsterdam Center for Drug Research (LACDR), Leiden, Netherlands

D. Brayden

University College Dublin, Dublin, Ireland

C. Caramella

Università degli Studi di Pavia, Pavia, Italy

A. Dahan

Ben-Gurion University of the Negev, Israel

M. Davies

The University of Nottingham, Nottingham, UK

S.C. De Smedt

Universiteit Gent, Gent, Belgium
University of Florida, Gainesville, Florida, USA

M. Eichelbaum

Dr. Margarete Fischer-Bosch Inst., Stuttgart, Germany

A. Fahr

Friedrich-Schiller-Universität Jena, Jena, Germany

M. Finel

University of Helsinki, Helsinki, Finland

S.Y.K Fong

University of Southern Denmark, Odense, Denmark

G. Fricker

Institut für Pharmazie und Molekulare Biotechnologie, Heidelberg, Germany
Rijksuniversiteit Groningen, Groningen, Netherlands

G. Garbacz

Physiolution GmbH, Greifswald, Germany

G. Golomb

Hebrew University of Jerusalem, Jerusalem, Israel
University of Bath, Bath, UK

J. Hirvonen

University of Helsinki, Helsinki, Finland

R. Holm

Lundbeck Copenhagen

P. Honkakoski

University of Eastern Finland, Kuopio, Finland

L. Illum

IDentity / Cosmas-Damian Ltd., Nottingham, UK

G. Imanidis

Universität Basel, Basel, Switzerland

K.-I. Inui

Kyoto Pharmaceutical University, Kyoto, Japan

H.E. Junginger

M.O. Karlsson

Uppsala Universitet, Uppsala, Sweden

J. Kopecek

University of Utah, Salt Lake City, UT, USA

R. Kostiainen

University of Helsinki, Helsinki, Finland

R. Langer

Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

C.-M. Lehr

Helmholtz-Institute for Pharmaceutical Research and Saarland University, Saarbrücken, Germany

H. Lennernäs

Uppsala Universitet, Uppsala, Sweden
University of Athens, Athens, Greece

U. Massing

KTB Klinik für Tumorbiologie, Freiburg, Germany

C. Middaugh

University of Kansas, Lawrence, Kansas, USA

S. Mitragotri, MS, PhD

Harvard University, Cambridge, Massachusetts, USA

C. O'Driscoll

University College Cork, Cork, Ireland

O. Pelkonen

University of Oulu, Oulu, Finland

G. Perlovich

Russian Academy of Sciences, Ivanovo, Russian Federation

J.E. Polli

University of Maryland, Baltimore, Maryland, USA

J.P. Remon

Universiteit Gent, Ghent, Belgium

J.S. Remy

Université de Strasbourg, Illkirch, France

R.C. Rowe

University of Bradford, Bradford, West Yorkshire, UK

W. Sadée

The Ohio State University, Columbus, Ohio, USA

E.H. Schacht

Universiteit Gent, Gent, Belgium
Université de Lille, Lille, France

E. B. Souto

Universidade de Coimbra, Coimbra, Portugal

S. Spampinato

Università di Bologna, Bologna, Italy

G. Storm

Universiteit Utrecht, Utrecht, Netherlands

Y. Sugiyama

The University of Tokyo, Tokyo, Japan

Y. Takakura

Kyoto University, Kyoto, Japan

G.T. Tucker

University of Sheffield, Sheffield, UK

K. Uekama

Kumamoto University, Kumamoto, Japan

K. Ulbrich

Academy of Sciences of the Czech Republic, Prague, Czech Republic

A. Urtti

University of Helsinki, Helsinki, Finland

H. van de Waterbeemd

Saint Andre, France

M.R. Vert

Université de Montpellier, Montpellier, France

S. Visser

Merck Research Laboratories, North Wales, Pennsylvania, USA
Ludwig-Maximilians-Universität München (LMU), München, Germany

M. Yliperttula

University of Helsinki, Helsinki, Finland


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug